BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8146549)

  • 1. [Chronic myeloid leukemia. Diagnosis, treatment].
    Guilhot F
    Rev Prat; 1993 Nov; 43(17):2263-8. PubMed ID: 8146549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic myeloid leukemia. Diagnosis, evolution and prognosis, treatment].
    Reiffers J; Montastruc M; Bilhou-Nabera C
    Rev Prat; 1990 Sep; 40(20):1879-85. PubMed ID: 1699264
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic myeloid leukemia].
    Gratwohl A; Favre G
    Rev Med Suisse; 2005 Jun; 1(24):1631-5. PubMed ID: 16028709
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic myeloid leukemia. Diagnosis, course, prognosis].
    Lacotte-Thierry L; Guilhot F
    Rev Prat; 1999 Feb; 49(3):339-43. PubMed ID: 10189806
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic myeloid leukemia. State of the art, May 1993].
    Hehlmann R
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):37-43. PubMed ID: 8296189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic myeloid leukemia. Diagnosis, course, prognosis].
    Mahon FX; Reiffers J
    Rev Prat; 1996 Nov; 46(18):2231-4. PubMed ID: 8978180
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic myeloid leukemia--pathophysiology and diagnosis].
    Stoetzer OJ; Hentrich M; Salat C
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2618-20. PubMed ID: 12469274
    [No Abstract]   [Full Text] [Related]  

  • 10. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
    Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
    Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current approaches to prognosis in chronic myeloid leukemia].
    Petukhov VI
    Ter Arkh; 1989; 61(2):129-32. PubMed ID: 2658188
    [No Abstract]   [Full Text] [Related]  

  • 12. New insights into the pathobiology and treatment of chronic myelogenous leukemia.
    Cotta CV; Bueso-Ramos CE
    Ann Diagn Pathol; 2007 Feb; 11(1):68-78. PubMed ID: 17240312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential clinical implications of early diagnosis of chronic myeloid leukemia.
    Haematologica; 1999 Apr; 84(4):289-90. PubMed ID: 10190939
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic myeloid leukemia--case report].
    Hentrich M; Stoetzer OJ; Salat C; Ledderose G
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2617. PubMed ID: 12469273
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ten years of molecular monitoring of chronic myeloid leukemia by quantitative RT-PCR].
    Moravcová J; Brdicka R
    Cas Lek Cesk; 2005; 144(1):32-7. PubMed ID: 15789779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the chronic leukemias: special considerations in the elderly patient. Part III rarer chronic myeloid leukemias.
    Spiers AS
    Hematology; 2002 Feb; 7(1):1-8. PubMed ID: 12171771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia].
    Rejtó L; Balázs M; Adány R; Rák K; Telek B; Kiss A; Ujj G; Mezei G; Balogh E; Udvardy M
    Orv Hetil; 2000 Sep; 141(39):2133-7. PubMed ID: 11028176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advancements in the treatment of chronic myelogenous leukemia.
    O'Dwyer ME; Mauro MJ; Druker BJ
    Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
    Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of chronic myelogenous leukemia].
    Rousselot P
    Rev Prat; 2005 Oct; 55(15):1647-57. PubMed ID: 16334201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.